Cargando…

Drug repositioning in cancer: The current situation in Japan

Cancer is a leading cause of death worldwide, and the incidence continues to increase. Despite major research aimed at discovering and developing novel and effective anticancer drugs, oncology drug development is a lengthy and costly process, with high attrition rates. Drug repositioning (DR, also r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Masuda, Takaaki, Tsuruda, Yusuke, Matsumoto, Yoshihiro, Uchida, Hiroki, Nakayama, Keiichi I., Mimori, Koshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156828/ https://www.ncbi.nlm.nih.gov/pubmed/31957175 http://dx.doi.org/10.1111/cas.14318

Ejemplares similares

Artificial intelligence-assisted drug repurposing via “chemical-induced gene expression ranking”
por: Masuda, Takaaki, et al.
Publicado: (2022)

Phase I dose‐escalation trial to repurpose propagermanium, an oral CCL2 inhibitor, in patients with breast cancer
por: Masuda, Takaaki, et al.
Publicado: (2020)

Overcoming Obstacles to Drug Repositioning in Japan
por: Nishimura, Yuhei, et al.
Publicado: (2017)

N-Cadherin mRNA Levels in Peripheral Blood Could Be a Potential Indicator of New Metastases in Breast Cancer: A Pilot Study
por: Masuda, Takaaki, et al.
Publicado: (2020)

Potential association of LOXL1 with peritoneal dissemination in gastric cancer possibly via promotion of EMT
por: Hu, Qingjiang, et al.
Publicado: (2020)

Current state and outlook for drug repositioning anticipated in the field of ovarian cancer
por: Kobayashi, Yusuke, et al.
Publicado: (2018)

Potentials of C‐C motif chemokine 2–C‐C chemokine receptor type 2 blockers including propagermanium as anticancer agents
por: Yumimoto, Kanae, et al.
Publicado: (2019)

Response Predictive Markers and Synergistic Agents for Drug Repositioning of Statins in Ovarian Cancer
por: Kobayashi, Yusuke, et al.
Publicado: (2022)

Oncogenic splicing abnormalities induced by DEAD ‐Box Helicase 56 amplification in colorectal cancer
por: Kouyama, Yuta, et al.
Publicado: (2019)

MicroRNAs as Biomarkers in Colorectal Cancer
por: Masuda, Takaaki, et al.
Publicado: (2017)

Oxysterol binding protein-like 3 (OSBPL3) is a novel driver gene that promotes tumor growth in part through R-Ras/Akt signaling in gastric cancer
por: Hu, Qingjiang, et al.
Publicado: (2021)

Drug Repositioning for Gynecologic Tumors: A New Therapeutic Strategy for Cancer
por: Banno, Kouji, et al.
Publicado: (2015)

A case of a patient receiving combination therapy with paclitaxel plus bevacizumab and adoptive activated αβ T‐cell immunotherapy in advanced breast cancer
por: Masuda, Takaaki, et al.
Publicado: (2020)

Drug repositioning of mevalonate pathway inhibitors as antitumor agents for ovarian cancer
por: Kobayashi, Yusuke, et al.
Publicado: (2017)

Hot spring bathing practices have a positive effect on mental health in Japan
por: Takeda, Midori, et al.
Publicado: (2023)

Successful Treatment with Hepatic Arterial Infusion Chemotherapy in a Breast Cancer Patient with Multiple Liver Metastases Who Declined Systemic Therapy
por: Masuda, Takaaki, et al.
Publicado: (2021)

Identification of serum microRNAs as potential diagnostic biomarkers for detecting precancerous lesions of gastric cancer
por: Otsu, Hajime, et al.
Publicado: (2022)

Editorial: Drug Repositioning: Current Advances and Future Perspectives
por: Nishimura, Yuhei, et al.
Publicado: (2018)

GET4 is a novel driver gene in colorectal cancer that regulates the localization of BAG6, a nucleocytoplasmic shuttling protein
por: Koike, Kensuke, et al.
Publicado: (2021)

From drug repositioning to target repositioning: prediction of therapeutic targets using genetically perturbed transcriptomic signatures
por: Namba, Satoko, et al.
Publicado: (2022)

Internet Medical Usage in Japan: Current Situation and Issues
por: Tatsumi, Haruyuki, et al.
Publicado: (2001)

Health Policy in Japan – Current Situation and Future Challenges
por: Matsuda, Shinya
Publicado: (2019)

Current situation of telemedicine research for cardiovascular risk in Japan
por: Shibata, Shigeru, et al.
Publicado: (2023)

Impaired tumor immune response in metastatic tumors is a selective pressure for neutral evolution in CRC cases
por: Sakimura, Shotaro, et al.
Publicado: (2021)

A Preliminary Survey on Clinical Practice for Children and Adolescents with Gender Dysphoria in Japan: Current Situation and Challenges
por: Tateno, Masaru, et al.
Publicado: (2019)

Current Status of COVID-19 Therapies and Drug Repositioning Applications
por: Altay, Ozlem, et al.
Publicado: (2020)

Editorial: Pharmacovigilance and drug repositioning research using pharmacoepidemiology
por: Noguchi, Yoshihiro, et al.
Publicado: (2023)

Preventive and promotive effects of habitual hot spa-bathing on the elderly in Japan
por: Maeda, Toyoki, et al.
Publicado: (2018)

Repositioning Drugs for Psychiatry
por: Akhondzadeh, Shahin
Publicado: (2020)

Pharmaceutical company perspectives on current safety risk communications in Japan
por: Urushihara, Hisashi, et al.
Publicado: (2014)

Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning
por: Adasme, Melissa F., et al.
Publicado: (2020)

Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents
por: Zhu, Sha, et al.
Publicado: (2022)

Targeting NPL4 via drug repositioning using disulfiram for the treatment of clear cell renal cell carcinoma
por: Yoshino, Hirofumi, et al.
Publicado: (2020)

Regulome-based characterization of drug activity across the human diseasome
por: Iwata, Michio, et al.
Publicado: (2022)

Novel and classic approaches for managing gastrointestinal cancers
por: Mimori, Koshi
Publicado: (2023)

The Current Status of Drug Repositioning and Vaccine Developments for the COVID-19 Pandemic
por: Won, Jung-Hyun, et al.
Publicado: (2020)

A Review of Current In Silico Methods for Repositioning Drugs and Chemical Compounds
por: He, Binsheng, et al.
Publicado: (2021)

Current situation regarding lead exposure in birds in Japan (2015–2018); lead exposure is still occurring
por: ISHII, Chihiro, et al.
Publicado: (2020)

Pediatric drug development in Japan: Current issues and perspectives
por: Saitou, Hiroyuki, et al.
Publicado: (2020)

Current Measures on Radioactive Contamination in Japan: A Policy Situation Analysis
por: Gilmour, Stuart, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_n7tebtt624rcoqb0u70enlqd50